Biolife Solutions (BLFS) Cash & Current Investments (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Cash & Current Investments data on file, last reported at $81.0 million in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $81.0 million, down 8.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $81.0 million (down 8.56% YoY), and the FY2025 annual result was $88.9 million, down 11.72% from the prior year.
• Cash & Current Investments fell to $81.0 million in Q1 2026 per BLFS's latest filing, from $88.9 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $100.7 million in Q4 2024 and troughed at $19.1 million in Q1 2023.
• A 5-year average of $55.3 million and a median of $59.5 million in 2022 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2023 and 2025: Cash & Current Investments slumped 68.73% in 2023, then jumped 270.9% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $62.7 million in 2022, then decreased by 29.53% to $44.2 million in 2023, then soared by 127.99% to $100.7 million in 2024, then fell by 11.72% to $88.9 million in 2025, then dropped by 8.92% to $81.0 million in 2026.
• Business Quant data shows BLFS's Cash & Current Investments at $81.0 million in Q1 2026, $88.9 million in Q4 2025, and $79.0 million in Q3 2025.